ARCHIVES

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006

Trials Approved by NCI CTEP For the Month of January

January 27, 2012